| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.15B | -19.9% |
| Gross profit | ¥0.05B | — |
| Operating income | ¥0.01B | — |
| Net income | ¥0.00B | -78.5% |
| Gross margin | 33.6% | Net margin 1.5% |
| Revenue Q/Q | -48.8% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.10B | 66.4% |
| R&D | ¥0.02B | 10.4% |
| SG&A | ¥0.05B | 31.4% |
| Tax & other | ¥0.00B | 2.2% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
晨光生物 ・ 晓程科技 ・ 节能环境 ・ 和顺电气 ・ 沃森生物 ・ 盈康生命 ・ 宋城演艺 ・ 南方泵业 ・ 汤臣倍健 ・ *ST香雪 ・ 天舟文化 ・ 睿智医药
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies